solutions syneos-one 
pharmaphorum
NOVEMBER 19, 2021
Marie Emms, vice president of site and patient participation at Syneos Health, tells us technology helped increase patient enrolment, improve diversity and inclusion, and boost retention rates for clinical trials after the pandemic. Still, she says a lot needs to be done to continue this upward trajectory.
Drug Discovery World
OCTOBER 18, 2022
The Clinical Trials Environmental Impact Community of Interest (CoI) was started by Pistoia Alliance member, Syneos Health. In phase one, the Community of Interest will work to collectively agree the parameters and variables that will be measured. . Growing pressure on life sciences.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 18, 2020
19, 2020 (GLOBE NEWSWIRE) — Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the Company has been named to the Forbes 2020 list of World’s Be s t Employers , ranking highest among biopharmaceutical outsourcing organizations. MORRISVILLE, N.C.,
XTalks
MARCH 5, 2021
The acquisition will see ICON plc, global provider of development and commercialization services to the pharmaceutical, biotechnology and medical device industries, expand its portfolio to leverage PRA’s mobile and connected health platforms, along with its data and information solutions. Accelerating Development. Siteless Operations.
pharmaphorum
FEBRUARY 1, 2022
He joined Sensyne from Syneos where he was global SVP capital solutions at Syneos One and has held senior positions at BenevolentAI, as chief business officer, BDO as head of life sciences in the UK, Results Healthcare, as a partner and co-lead of its healthcare practice and Quintiles where Martin led M&A in Europe.
XTalks
FEBRUARY 9, 2023
This webinar features industry experts from Medable, Syneos and Veeva who share best practices and examples on how to successfully implement and scale patient-first DCTs across an organization to drive transformation of the clinical development process while mitigating potential risks.
ACRP blog
DECEMBER 28, 2022
Earlier in December, Syneos Health ® , a biopharmaceutical solutions organization, released its collection of 2023 Health Trends: Personally, Purposely Building What’s Next. M]aybe at first, all we’re doing is taking a process that costs a human 20 clicks on a mouse and reducing it to five, or just one,” Householder explained.
Expert insights. Personalized for you.
52 
Let's personalize your content